IL-3 is a novel target to interfere with tumor vasculature

Characterization of Molecular and Functional Alterations of Tumor Endothelial Cells to Design Anti-Angiogenic Strategies

(2010) Benedetta Bussolati et al.   Current Vascular Pharmacology

Unacylated Ghrelin Rescues Endothelial Progenitor Cell Function in Individuals With Type 2 Diabetes

(2010) G. Togliatto et al.   DIABETES

Inhibition of β1 integrin and IL-3Rβ common subunit interaction hinders tumour angiogenesis

(2010) B Uberti et al.   ONCOGENE

Interleukin-3 promotes expansion of hemopoietic-derived CD45+ angiogenic cells and their arterial commitment via STAT5 activation

(2008) A. Zeoli et al.   BLOOD

Bony Endothelium: Tumor-Mediated Transdifferentiation?

(2008) Catherine M. Verfaillie   CANCER CELL

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE

Tumor Angiogenesis

(2008) Robert S. Kerbel   NEW ENGLAND JOURNAL OF MEDICINE